Risk Factors for Quinolone Resistance Among ESBL Producing Klebsiella Species

Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli

NCT00300560 ·Status: UNKNOWN ·Phase: PHASE3

Type VI Secretion System in Klebsiella Pneumoniae

NCT05516654 ·Status: UNKNOWN

Gram Negative Bacteremia, Risk Factors for Failure of Therapy

NCT00177957 ·Status: COMPLETED

Epidemiology of Klebsiella Pneumoniae in China

NCT03598543 ·Status: UNKNOWN

Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China

NCT03245632 ·Status: UNKNOWN

Incidence and Risk Factors for Developing Infections in Patients Colonized by CP-KPC

NCT05492539 ·Status: UNKNOWN

Clinical Outcomes of Hypervirulent Carbapenem-resistant Klebsiella Pneumoniae Infection

NCT06190548 ·Status: COMPLETED

NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria

NCT05017766 ·Status: RECRUITING

PREdiction of CEphalosporinase Producing Enterobacteria During Ventilator-associated Pneumonia for Therapeutic Stewardship

NCT05486130 ·Status: UNKNOWN

Dose Optimization by Pharmacokinetic/Pharmacodynamic of Antibiotics to Improve Clinical Outcome of Carbapenem Resistant Klebsiella Pneumoniae Bloodstream Infections in Critically Ill Patients at Phramongkutklao Hospital

NCT05862402 ·Status: UNKNOWN ·Phase: PHASE4

Emergence of Fluoroquinolone Resistance in Commensal Flora

NCT01209247 ·Status: COMPLETED ·Phase: NA

Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin

NCT00414362 ·Status: COMPLETED

Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia

NCT05613322 ·Status: TERMINATED

Predictors of Rates of Resistant Gram-Negative Bacteria

NCT01075009 ·Status: COMPLETED

Discontinuation of Antibiotic Susceptibility Testing on Enterococcus Faecalis Positive Urine Cultures in Hospitalized Patients: an Impact on Antibiotic Prescriptions? (FaecaCible)

NCT05743192 ·Status: COMPLETED

Comparative Clinical Study Between Colistin-Tigecycline Combined Therapy Versus Colistin-Meropenem Combined Therapy in Treatment of Blood Stream Infections With Multidrug-Resistant Klebsiella Pneumoniae

NCT04489459 ·Status: UNKNOWN ·Phase: PHASE4

Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)

NCT01597973 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli

NCT02474706 ·Status: TERMINATED ·Phase: PHASE4

Colistin-rifampin Combination and Colistin Monotherapy in Extensively Drug-resistant Acinetobacter Baumannii

NCT03622918 ·Status: COMPLETED ·Phase: NA

Detection of Colistin-resistant Isolates From Patients of Intensive Care Units and Oncohaematology Wards.

NCT03971877 ·Status: COMPLETED

Population Pharmacokinetic Study of Colistin in Patients Infected With Multiresistant Gram-negative Bacteria

NCT01060891 ·Status: COMPLETED ·Phase: PHASE1

Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae

NCT02681263 ·Status: UNKNOWN ·Phase: PHASE4

Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036)

NCT00235690 ·Status: COMPLETED ·Phase: NA

MOdification Of THe Early-Life Respiratory Microbiome Through Vaginal SEEDing

NCT05505110 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Coagulation and Fibrinolysis as Virulence Factors for Invasive Staphylococcus Aureus and Streptococcus Infections

NCT01731483 ·Status: COMPLETED